Top

Published in:

Open Access 01-12-2020 | Bronchial Asthma | Study protocol

Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study

Authors: Esther T. Sportel, Martijn J. Oude Wolcherink, Job van der Palen, Anke Lenferink, Boony J. Thio, Kris L. L. Movig, Marjolein G. J. Brusse-Keizer

Published in: Trials | Issue 1/2020

Abstract

Background

Many asthmatic children suffer from uncontrolled asthma with frequent exacerbations, despite an optimal treatment plan using inhalation medication. Studies have shown that therapy adherence and inhalation technique are often suboptimal in asthmatic children, but these have traditionally been hard to measure. A novel device functioning as an add-on to the inhaler has been developed to measure both aspects by recording vibration patterns during inhalation. This data can be converted to smart feedback and provided to patients immediately via a mobile application. The aim of this study is to improve asthma control in children between 6 and 18 years old by providing immediate smart feedback on the intake of inhalation medication. Asthma control will be measured by forced expiratory volume in 1 s, (Childhood) Asthma Control Test ((c-)ACT) score, and lung function variability and reversibility.

Methods

The study will be performed in Medisch Spectrum Twente (Enschede, The Netherlands). The goal is to include 68 uncontrolled moderate to severe asthmatic children between 6 and 18 years old who receive controller inhalation medication through the Nexthaler®, Ellipta®, or Spiromax®. The study consists of three phases. Phase 1 is observational and will last 4 weeks to observe the baseline adherence and inhalation technique as monitored by the add-on device. A randomised controlled trial lasting 6 weeks will be performed in phase 2. Patients in the intervention group will receive immediate smart feedback about the performed inhalations via a mobile application. In the control group, adherence and inhalation technique will be monitored, but patients will not receive feedback. In phase 3, also lasting 6 weeks, the feedback will be ceased for all children and revision of current therapy may occur, depending on the findings in phase 2. Asthma control can be assessed by means of spirometry (both at home and in the hospital) and (c-)ACT questionnaires.

Discussion

Immediate smart feedback may improve therapy adherence and inhalation technique, and thus asthma control in children and prevent unnecessary switches to targeted biologics. Performing this study in children is desired, since they are known to react differently to feedback and medication than adults.

Trial registration

Dutch Trial Register NL7705. Registered on 29 April 2019

Global Initiative for Asthma. Pocket guide for asthma management and prevention. 2019. www.ginasthma.org. Accessed 28 June 2020.

Nielen MMJ, Poos MJJC, Wijga AH, Gommer AM. Prevalentie astma in huisartsenpraktijk. 2019. https://www.volksgezondheidenzorg.info/onderwerp/astma/cijfers-context/huidige-situatie#node-prevalentie-astma-huisartsenpraktijk. Accessed 28 June 2020.

Plasmans MHD, Ramjiawan VR, Vonk RAA, Giesbers H. Zorguitgaven astma naar sector. 2019. https://www.volksgezondheidenzorg.info/onderwerp/astma/kosten/zorguitgaven#node-zorguitgaven-astma-naar-sector. Accessed 28 June 2020.

Zorginstituut Nederland. Astma | Farmacotherapeutisch Kompas. 2015. https://www.farmacotherapeutischkompas.nl/bladeren/indicatieteksten/astma#astma_astma__aanvalsbehandeling_literatuur. Accessed 28 June 2020.

Bindels PJE, Van de Griendt EJ, Grol MH, et al. Astma Bij Kinderen | NHG-Richtlijnen; 2014. https://richtlijnen.nhg.org/standaarden/astma-bij-kinderen. Accessed 28 June 2020.

Liu AH, Gilsenan AW, Stanford RH, Lincourt W, Ziemiecki R, Ortega H. Status of asthma control in pediatric primary care: results from the pediatric Asthma Control Characteristics and Prevalence Survey Study (ACCESS). J Pediatr. 2010;157(2):276–281.e3. https://doi.org/10.1016/j.jpeds.2010.02.017.CrossRefPubMed

Guilbert TW, Bacharier LB, Fitzpatrick AM. Severe asthma in children. J Allergy Clin Immunol Pract. 2014;2(5):489–500. https://doi.org/10.1016/j.jaip.2014.06.022.CrossRefPubMedPubMedCentral

Lemanske RF, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975–85. https://doi.org/10.1056/NEJMoa1001278.CrossRefPubMedPubMedCentral

Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015. https://doi.org/10.1155/2015/217047.

10.

Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135(2):299–310. https://doi.org/10.1016/j.jaci.2014.12.1871.CrossRefPubMed

11.

Zorginstituut Nederland. Medicijnkosten | Omalizumab. https://www.medicijnkosten.nl/zoeken?trefwoord=Omalizumab. Accessed 28 June 2020.

12.

Kappy MS, Barton LL, Berkowitz CD, Carver J, Ziegler MM. Advances in pediatrics 2016, e-book: Elsevier Health Sciences; 2016. https://books.google.nl/books?id=eam-DAAAQBAJ&dq=airway+remodelling+asthma+depending+on+age&source=gbs_navlinks_s. Accessed 28 June 2020.

13.

Desai M, Oppenheimer JJ. Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep. 2011;11(6):454–64. https://doi.org/10.1007/s11882-011-0227-2.CrossRefPubMed

14.

Jentzsch NS, Camargos PAM, Colosimo EA, Bousquet J. Monitoring adherence to beclomethasone in asthmatic children and adolescents through four different methods. Allergy Eur J Allergy Clin Immunol. 2009;64(10):1458–62. https://doi.org/10.1111/j.1398-9995.2009.02037.x.CrossRef

15.

Gillette C, Rockich-Winston N, Kuhn JBA, Flesher S, Shepherd M. Inhaler technique in children with asthma: a systematic review. Acad Pediatr. 2016;16(7):605–15. https://doi.org/10.1016/j.acap.2016.04.006.CrossRefPubMed

16.

Klok T, Kaptein AA, Duiverman EJ, Brand PL. It’s the adherence, stupid (that determines asthma control in preschool children)! Eur Respir J. 2014;43(3):783–91. https://doi.org/10.1183/09031936.00054613.CrossRefPubMed

17.

Jochmann A, Artusio L, Jamalzadeh A, et al. Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children. Eur Respir J. 2017;50(6). https://doi.org/10.1183/13993003.00910-2017.

18.

Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med. 2011;105(12):1815–22. https://doi.org/10.1016/j.rmed.2011.07.004.CrossRefPubMed

19.

Axelsson M, Emilsson M, Brink E, Lundgren J, Torén K, Lötvall J. Personality, adherence, asthma control and health-related quality of life in young adult asthmatics. Respir Med. 2009;103(7):1033–40. https://doi.org/10.1016/j.rmed.2009.01.013.CrossRefPubMed

20.

Tashkin DP, Rand C, Nides M, et al. A nebulizer chronolog to monitor compliance with inhaler use. Am J Med. 1991;91(4 SUPPL. 1). https://doi.org/10.1016/0002-9343(91)90260-5.

21.

Spaulding SA, Devine KA, Duncan CL, Wilson NW, Hogan MB. Electronic monitoring and feedback to improve adherence in pediatric asthma. J Pediatr Psychol. 2012;37(1):64. https://doi.org/10.1093/JPEPSY/JSR059.CrossRefPubMed

22.

Sulaiman I, Greene G, MacHale E, et al. A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma. Eur Respir J. 2018;51(1). https://doi.org/10.1183/13993003.01126-2017.

23.

van der Kamp M. WEARCON: wearable home-monitoring in asthmatic children; 2017.

24.

Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol. 2009;124(4):719–723.e1. https://doi.org/10.1016/j.jaci.2009.06.053.CrossRefPubMed

25.

Koehorst-Ter Huurne K, Kort S, Van Der Palen J, et al. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related. Int J COPD. 2016;11(1):1679–88. https://doi.org/10.2147/COPD.S107303.CrossRef

26.

Laube BL, Janssens HM, De Jongh FHC, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–31. https://doi.org/10.1183/09031936.00166410.CrossRefPubMed

27.

Holmes MS, D’Arcy S, Costello RW, Reilly RB. Acoustic analysis of inhaler sounds from community-dwelling asthmatic patients for automatic assessment of adherence. IEEE J Transl Eng Heal Med. 2014;2(1). https://doi.org/10.1109/JTEHM.2014.2310480.

28.

Suresh K. An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011;4(1):8. https://doi.org/10.4103/0974-1208.82352.CrossRefPubMedPubMedCentral

29.

Kersten ETG, Van Leeuwen JC, Brand PLP, et al. Effect of an intranasal corticosteroid on exercise induced bronchoconstriction in asthmatic children. Pediatr Pulmonol. 2012;47(1):27–35. https://doi.org/10.1002/ppul.21511.CrossRefPubMed

30.

King TS, Lengerich R, Bai S. Frequentist methods: O’Brien-Fleming, Pocock, Haybittle-Peto | STAT 509. 2018. https://online.stat.psu.edu/stat509/node/80/. Accessed 29 June 2020.

31.

Ugoni A, Walker BF. The chi square test. An introduction, vol. 4; 1995.

32.

Krueger C, Tian L. A comparison of the general linear mixed model and repeated measures ANOVA using a dataset with multiple missing data points. Biol Res Nurs. 2004;6(2). https://doi.org/10.1177/1099800404267682.

33.

Kumar A, Chakraborty BS. Interim analysis: a rational approach of decision making in clinical trial. J Adv Pharm Technol Res. 2016;7(4):118–22. https://doi.org/10.4103/2231-4040.191414.CrossRefPubMedPubMedCentral

34.

Castro M, Kraft M. Clinical asthma: e-book. 1st ed: Elsevier Health Sciences; 2008. https://books.google.nl/books?id=y9WYwLVn7pgC&dq=quality+of+life+children+asthma+adapt+lifestyle&source=gbs_navlinks_s. Accessed 29 June 2020.

35.

Nikander K, Turpeinen M, Pelkonen AS, Bengtsson T, Selroos O, Haahtela T. True adherence with the Turbuhaler in young children with asthma. Arch Dis Child. 2011;96(2):168–73. https://doi.org/10.1136/adc.2010.187724.CrossRefPubMed

36.

Chrystyn H, van der Palen J, Sharma R, et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med. 2017;27(1):22. https://doi.org/10.1038/s41533-017-0016-z.CrossRefPubMedPubMedCentral

37.

Kaplan A, Price D. Matching inhaler devices with patients: the role of the primary care physician. Can Respir J. 2018;2018. https://doi.org/10.1155/2018/9473051.

38.

Brand PLP, Mäkelä MJ, Szefler SJ, Frischer T, Price D. Monitoring asthma in childhood: symptoms, exacerbations and quality of life. Eur Respir Rev. 2015;136(24). https://doi.org/10.1183/16000617.00003614.

39.

Thomas M, Kay S, Pike J, et al. The Asthma Control Test™ (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J. 2009;18(1):41–9. https://doi.org/10.4104/pcrj.2009.00010.CrossRefPubMedPubMedCentral

40.

Solomon P, Cavanaugh MM, Draine J. Randomized controlled trials: design and implementation for community-based psychosocial interventions: Oxford University Press; 2009. https://books.google.nl/books?id=XHnzcAZjMTwC&dq=randomised+control+trial&source=gbs_navlinks_s. Accessed 29 June 2020.

41.

Adair JG. The Hawthorne effect: a reconsideration of the methodological artifact. J Appl Psychol. 1984;69(2):334–45. https://doi.org/10.1037/0021-9010.69.2.334.CrossRef

42.

Krakowiak K, Durrington HJ. The role of the body clock in asthma and COPD: implication for treatment. Pulm Ther. 2018;4(1):29–43. https://doi.org/10.1007/s41030-018-0058-6.CrossRefPubMedPubMedCentral

43.

Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med. 2008;5(8):1180–2. https://doi.org/10.1371/journal.pmed.0050172.CrossRef

Title: Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study
Authors: Esther T. Sportel
Martijn J. Oude Wolcherink
Job van der Palen
Anke Lenferink
Boony J. Thio
Kris L. L. Movig
Marjolein G. J. Brusse-Keizer
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Bronchial Asthma
Spirometry
Published in: Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-020-04694-4

At a glance: The STEP trials

Springer Medicine

Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study

Abstract

Background

Methods

Discussion

Trial registration

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2020

Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials

The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial

Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial

A novel method for interpreting survival analysis data: description and test on three major clinical trials on cardiovascular prevention

Using metagenomic analysis to assess the effectiveness of oral health promotion interventions in reducing risk for pneumonia among patients with stroke in acute phase: study protocol for a randomized controlled trial

An investigation into the factors affecting investigator-initiated trial start-up in Ireland